GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding GENELUX Corp changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 0 | 21 | +21 |
| Shares | 0 | 287.4K | +287.4K |
| Value | $0 | $7.97M | +$7.97M |
New holders (21)
Institutions that held GENELUX Corp at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 67,658 | $1.88M | 0.00% |
| Hohimer Wealth Management, LLC | 44,940 | $1.25M | 0.36% |
| Geode Capital Management, LLC | 37,709 | $1.05M | 0.00% |
| Barclays PLC | 33,178 | $920.4K | 0.00% |
| Axxcess Wealth Management, LLC | 16,668 | $462.4K | 0.04% |
| Charles Schwab Investment Management Inc | 15,176 | $421.0K | 0.00% |
| BlackRock Inc. | 14,501 | $402.3K | 0.00% |
| Northern Trust Corp | 11,185 | $310.3K | 0.00% |
| Citadel Advisors LLC | 10,615 | $294.5K | 0.00% |
| Millennium Management LLC | 8,763 | $243.0K | 0.00% |
| Goldman Sachs Group Inc | 8,647 | $239.9K | 0.00% |
| State Street Corp | 7,700 | $213.6K | 0.00% |
| Citigroup Inc | 3,031 | $84.1K | 0.00% |
| Morgan Stanley | 1,984 | $55.0K | 0.00% |
| Royal Bank of Canada | 2,000 | $55.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,147 | $32.0K | 0.00% |
| Wells Fargo & Company | 1,018 | $28.2K | 0.00% |
| Advisor Group Holdings, Inc. | 1,001 | $27.8K | 0.00% |
| UBS Group AG | 184 | $5.10K | 0.00% |
| Allworth Financial LP | 162 | $4.49K | 0.00% |
| JPMorgan Chase & Co | 100 | $3.00K | 0.00% |
Sold out (0)
Institutions that held GENELUX Corp at the end of Q4 2022 and filed for Q1 2023 without it.
None.